Fragile spreadsheets bottlenecked deal modeling. Now, AI summarizes variances and flags risks, freeing analysts to shape strategy.
A biopharmaceutical company focused on oncology and rare diseases relies heavily on acquisitions for growth, making rapid financial evaluation critical for every potential deal.
Evaluating acquisition scenarios was painfully slow because the finance team relied on fragile, layered spreadsheets that required constant manual...
“We’re very acquisitive, so we are constantly looking for deal opportunities.”
Biopharmaceutical company developing and commercializing specialty pharmaceuticals.
AI-powered financial planning, budgeting, and performance management platform.
TerSera Therapeutics's Financial planning is part of this use case:
Related implementations across industries and use cases
Teams reactively managed trials across scattered systems. AI now integrates data to predict bottlenecks and recommend interventions.
Writers spent weeks sifting through data to draft reports. AI now generates a 14-section first draft in minutes for review.
Managers hedged budgets, leaving capital frozen. AI agents now reallocate funds in real time, freeing €1B for new discoveries.
Treasurers scrambled off-hours to manually calculate cash flow. Now, AI continuously monitors risks and offers to move funds directly.
Forecasting was a manual "Excel Olympics." AI now scores deals and flags risks, freeing leaders to coach instead of gathering data.
Insurance bottlenecks delayed critical therapies for months. Now, AI verifies coverage, freeing care teams to guide patients to treatment.
Manual scheduling trapped recruiters in logistics. AI now automates interview coordination, freeing teams for strategic work.
Manual spot-checks missed duplicates. AI now audits 100% of spend, catching $20k in errors and reclaiming 160 hours for analysis.
Rebuilding client context bottlenecked tax teams for weeks. Now, custom AI agents evaluate returns, empowering staff to finish in one day.
Fragile spreadsheets bottlenecked deal modeling. Now, AI summarizes variances and flags risks, freeing analysts to shape strategy.
A biopharmaceutical company focused on oncology and rare diseases relies heavily on acquisitions for growth, making rapid financial evaluation critical for every potential deal.
Evaluating acquisition scenarios was painfully slow because the finance team relied on fragile, layered spreadsheets that required constant manual...
“We’re very acquisitive, so we are constantly looking for deal opportunities.”
Biopharmaceutical company developing and commercializing specialty pharmaceuticals.
AI-powered financial planning, budgeting, and performance management platform.
TerSera Therapeutics's Financial planning is part of this use case:
Related implementations across industries and use cases
Teams reactively managed trials across scattered systems. AI now integrates data to predict bottlenecks and recommend interventions.
Writers spent weeks sifting through data to draft reports. AI now generates a 14-section first draft in minutes for review.
Managers hedged budgets, leaving capital frozen. AI agents now reallocate funds in real time, freeing €1B for new discoveries.
Treasurers scrambled off-hours to manually calculate cash flow. Now, AI continuously monitors risks and offers to move funds directly.
Forecasting was a manual "Excel Olympics." AI now scores deals and flags risks, freeing leaders to coach instead of gathering data.
Insurance bottlenecks delayed critical therapies for months. Now, AI verifies coverage, freeing care teams to guide patients to treatment.
Manual scheduling trapped recruiters in logistics. AI now automates interview coordination, freeing teams for strategic work.
Manual spot-checks missed duplicates. AI now audits 100% of spend, catching $20k in errors and reclaiming 160 hours for analysis.
Rebuilding client context bottlenecked tax teams for weeks. Now, custom AI agents evaluate returns, empowering staff to finish in one day.